 |
인쇄하기
취소
|
Daewoong to announce positive results for DWP05195, chronic intractable painkiller
Daewoong Pharmaceutical says it has completed Phase 1 local clinical study of DWP05195, neuropathic painkiller, in 120 healthy volunteers with neuropathy.
"We are extremely pleased with the results of this 120 healthy volunteers Phase I clinical trial in Korea which clearly demonstrated an excellent efficacy and safety profile for neuropathy,” said a company official.
The company will car...
"We are extremely pleased with the results of this 120 healthy volunteers Phase I clinical trial in Korea which clearly demonstrated an excellent efficacy and safety profile for neuropathy,” said a company official.
The company will car...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.